MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Double trouble: Association of malignant melanoma with sporadic and genetic forms of Parkinson’s disease and asymptomatic carriers of related genes in the PPMI study.

    C. Koros, AM. Simitsi, A. Bougea, N. Papagiannakis, I. Pachi, A. Prentakis, R. Antonelou, A. Zahou, I. Beratis, E. Efthymiopoulou, E. Stanitsa, C. Chrysovitsanou, E. Angelopoulou, K. Lourentzos, V. Constantinides, M. Bozi, D. Papadimitriou, A. Bonakis, G. Paraskevas, C. Potagas, S. Papageorgiou, X. Trapali, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: The aim of the present study was to assess the prevalence of malignant melanoma (MM) in sporadic and genetic Parkinson’s disease (PD) patients and…
  • 2022 International Congress

    The Genetic Landscape of Parkinson’s disease in populations of non-Caucasian ancestry.

    C. Koros, AM. Simitsi, N. Papagiannakis, A. Bougea, I. Pachi, R. Antonelou, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: We aimed to review existing literature on the genetic background of Parkinson’s disease (PD) populations of non-Caucasian or mixed ancestry. Background: There has been…
  • 2022 International Congress

    In Silico Study Reveals Cocaine Exposure Modulates Dopamine Neuron Firing Patterns by Inhibiting Small Conductance Calcium Activated Potassium Current

    CHI. Mahapatra (Mumbai, India)

    Objective: The neurological reason behind the loss of dopamine neurons causing Parkinson’s disease (PD) is an unsolved mystery. Background: As PD is identified as a…
  • 2022 International Congress

    Optimizing patient-centric clinical outcome assessments for use in Parkinson’s disease clinical trials: Critical Path for Parkinson’s multistakeholder initiative

    R. Speck, D. Trundell, J. Cedarbaum, M. Campbell, P. Chin, S. Crawford, T. Dam, D. Dexter, A. Goldfine, K. Klapper, C. Kopil, S. Lee, K. Marek, H. Matthews, T. Mestre, T. Morel, M. Minchik, M. Müller, K. Schroeder, T. Simuni, G. Stebbins, C. Yan, ML. Zeissler, D. Stephenson (Tucson, USA)

    Objective: To advance patient-centric endpoints for use in early-stage Parkinson’s disease (PD) clinical trials. Background: Limitations with currently available patient-centric clinical outcome assessments (COAs) has…
  • 2022 International Congress

    Factors related to the antidepressant effect of safinamide in Parkinson’s disease. A post-hoc analysis of SADNESS-PD study

    E. Peña, C. Borrué, M. Mata, JC. Martínez-Castrillo, A. Alonso-Canovas, JL. Chico, L. López-Manzanares, M. Llanero, J. Herreros-Rodríguez, A. Esquivel, T. Maycas-Cepeda, C. Ruíz-Huete (Madrid, Spain)

    Objective: To assess the role of different factors in the antidepressant effect of safinamide in Parkinson’s disease (PD) Background: SADNESS-PD was a real-life, multicenter, retrospective…
  • 2022 International Congress

    Alprazolam reduces freezing of gait and improves freezing-related gait measures

    A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Relationship between gait speed and functional measurements in Parkinson’s disease

    D. Iucksch, B. Yamaguchi, L. Araujo, V. Israel (CURITIBA, Brazil)

    Objective: The present study aims to relate gait speed in Parkinson's disease (PD) with functional measures of muscle strength, balance and physical capacity. Background: PD…
  • 2022 International Congress

    Rapid onset of good ON time and improvement in motor-state stability in aPD patients after treatment with continuous subcutaneous foslevodopa/foscarbidopa

    R. Pahwa, M. Soileau, D. Standaert, V. Fung, T. Kimber, I. Malaty, A. Merola, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, N. Fisseha, A. Jeong, M. Facheris, P. Kukreja, J. Zamudio, J. Aldred (Kansas City, USA)

    Objective: To evaluate time to ON without troublesome dyskinesia (‘good ON’) and patterns of motor-state stability throughout the day in patients with advanced Parkinson’s disease…
  • 2022 International Congress

    Deep Brain Stimulation in Parkinson’s disease: Challenges of a young experience in southern Morocco

    Y. Naji, K. Saghir, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: The objective of our research was to describe the epidemiological, therapeutic features and effectiveness of deep brain stimulation in operated patients. To cite the…
  • 2022 International Congress

    MoCA and MMSE subitems’ sensitivity across the PD-cognitive spectrum

    E. Fiorenzato, L. Zurlo, C. Cianci, M. Garon, T. Gandolfi, F. Pistonesi, L. Weis, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To determine which Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) subitems are more sensitive in detecting cognitive abnormalities in patients with PD…
  • « Previous Page
  • 1
  • …
  • 337
  • 338
  • 339
  • 340
  • 341
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley